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TGFB1 REGULATION AND NOVEL THERAPIES FOR OSTEOARTHRITIS
P. Hopkins. New England Baptist Hosp., Roxbury, MA, USA
Purpose: Exploring the role of biomarkers in osteoarthritis and adhe-
sive capsulitis.
Methods: Pt was a 65 year old wm who presented 6 weeks post total
knee replacement with swelling and limited range of motion. His pre-
vious knee replacement was without complication. His range of motion
was limited to 85 degrees. His blood work showed a normal WBC, ESR,
CRP. His MMP1 and MMP 3 were elevated at 49% and 64% of inﬂam-
matory levels observed in Rheumatoid arthritis.
Results: The patient was placed on doxycyline 100 mg daily. After two
weeks of therapy all swelling had resolved, range of motion had
increased by 50% and pain had completely disappeared. He tolerated
the medication without any adverse events. The dose prescribed was
sub anti microbial.
Conclusions: Osteoarthritis (OA) is the most common form of arthritis,
affecting nearly 27 million people in the United States, and is a chronic
degenerative disorder affecting joint tissue in, e.g., the hands, feet, hips,
knees, or spine. Fibrosis of the surrounding muscle architecture has
been implicated in the development of advanced osteoarthritis.
Doxycycline is a semisynthetic, chemically modiﬁed tetracycline com-
pound that is rapidly absorbed when taken orally and topically, and
which exerts biological effects that are independent of antimicrobial
activity (Greenwald, Ann. N.Y. Acad. Sci., 732: 181-198, 1994).Although a number of investigated therapies against inﬂammatory
conditions, such as OA, have demonstrated palliative properties, these
therapies may not produce consistently beneﬁcial outcomes in subjects.
Therefore, there remains a need for methods to treat subjects with such
inﬂammatory conditions as well as methods to accurately diagnose the
presence of such inﬂammatory conditions in subjects.
Summary of the treatment protocol.
The case report features protocol for treating subjects with inﬂamma-
tory conditions, as well as methods for detecting inﬂammatory con-
ditions. Such inﬂammatory conditions may include, for example, mild
traumatic brain injury (mTBI), also known as concussion, osteoarthritis
(OA), ﬁbromyalgia, diabetic adhesive capsulitis, hypermobility syn-
drome, exercise intolerance, arthropathy, inﬂammatory bowel disease,
constipation, diabetes-associated inﬂammation, adhesion (e.g., post-
operative adhesion, post-operative adhesion after joint replacement
surgery, or abdominal adhesion), Ehlers-Danlos Syndrome, sarcopenia,
sarcoidosis, and liver ﬁbrosis. In various embodiments, the adhesion is
the result of injury, surgery (e.g., joint replacement surgery), or
inﬂammation. In some embodiments, the adhesion occurs in a joint,
tendon, ligament, eye, abdomen, pericardium, or pelvis. In certain
conditions, the joint is a shoulder joint, knee joint, hip joint, ankle joint,
elbow joint, or wrist joint.
We propose that the tetracycline derivatives have a therapeutic role in
treatment of many of the degenerative diseases associated with
inﬂammation, ﬁbrosis, adhesions and subsequent deterioration of the
joint. While historically research in the ﬁeld of degenerative arthritis
has focused on cartilage and bone we hypothesize that the extra-cel-
lural matrix[ECM] and the TGF pathway play a critical role in muscle
sarcopenia and subsequent joint degeneration. Discovery of a bio-
marker for a disease of such widespread catastrophic economic con-
sequence is critical at this time.Biomechanics & Gait
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GAIT CHARACTERISTICS THAT INFLUENCE CARTILAGE THICKNESS
ARE RELATED TO SERUM CONCENTRATIONS OF CARTILAGE
OLIGOMERIC MATRIX PROTEIN BEFORE AND AFTER A
MECHANICAL STIMULUS
E.F. Chehab y,z, M.R. Titchenal y,z, J.L. Asay y,z, T.P. Andriacchi y,z.
y Stanford Univ., Stanford, CA, USA; z Palo Alto VA, Palo Alto, CA, USA
Purpose: The serum concentration of cartilage oligomeric matrix pro-
tein (COMP) has been reported to be elevated in patients with knee
osteoarthritis (OA) and changes in serum COMP concentration due to a
mechanical stimulus (30 minute walk) were associated with cartilage
thinning over ﬁve years. However, it is not clear if there are speciﬁc
features of gait that inﬂuence pre-activity and post-activity COMP lev-
els. While several mechanical measures during walking have been
associated with morphological changes in cartilage, the association
between these mechanical measures and biomarkers in serum remains
unclear. Thus the purpose of this study was to test if speciﬁc gait
characteristics that have been shown to be associated with cartilage
thickness changes are also associated with serum COMP levels before
and after a 30-minutewalk.We tested the hypotheses that the ﬁrst peak
knee adduction moment (KAM), the ﬁrst peak knee ﬂexion moment
(KFM), the knee ﬂexion angle at heel-strike (KFA), and the anterior-
posterior position of the femur relative to the tibia at heel-strike (FP)
were related to baseline levels of COMP in serum as well as COMP levels
in serum 5.5 hours after a mechanical stimulus (mCOMP) in subjects
with and without knee OA.
Methods: An IRB-approved protocol was used to recruit and test 40
healthy subjects and 33 subjects with medial knee OA (Table 1). Blood
was drawn before and 5.5 hours after 30 minutes of walking at a self-
selected normal pace. Serum COMP levels were quantiﬁed using ELISA;
post-activity COMP level was expressed as a percentage of pre-activity
level. Gait mechanics during normal walking at a self-selected speed
were collected using optical motion capture and a ﬂoor-embedded
force plate; kinetic and kinematic measures were calculated using the
point cluster technique and inverse dynamics. Backward stepwise
regressions were used to assess which independent measures of KAM,
KFM, KFA, FP, age, gender, BMI, OA status, and KL grade were
